{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:15:33Z","timestamp":1784171733675,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012449","name":"Southern University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["21JCQNJC00230"],"award-info":[{"award-number":["21JCQNJC00230"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20272"],"award-info":[{"award-number":["U22A20272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110051"],"award-info":[{"award-number":["2021A1515110051"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2308085MH240"],"award-info":[{"award-number":["2308085MH240"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220530113609020"],"award-info":[{"award-number":["JCYJ20220530113609020"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2021QN02Y875"],"award-info":[{"award-number":["2021QN02Y875"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.intimp.2023.111168","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T15:53:12Z","timestamp":1699285992000},"page":"111168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Hydroxypropyl-\u03b2-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity"],"prefix":"10.1016","volume":"125","author":[{"given":"Mengmeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baotong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-3847","authenticated-orcid":false,"given":"Yuanli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2023.111168_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clbc.2016.05.012","article-title":"Classification, treatment strategy, and associated drug resistance in breast cancer","volume":"16","author":"Tang","year":"2016","journal-title":"Clin. Breast Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2023.111168_b0010","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.intimp.2023.111168_b0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.intimp.2023.111168_b0020","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.111168_b0025","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18888.1","article-title":"Triple-Negative Breast Cancer: Recent Treatment Advances","volume":"8","author":"Bergin","year":"2019","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.111168_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10549-018-4877-9","article-title":"Screening status, tumour subtype, and breast cancer survival: a national population-based analysis","volume":"172","author":"O'Brien","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.intimp.2023.111168_b0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.critrevonc.2014.06.004","article-title":"Lymphedema following breast cancer treatment and impact on quality of life: A review","volume":"92","author":"Taghian","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111168_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/107327481001700305","article-title":"A review of triple-negative breast cancer","volume":"17","author":"Ismail-Khan","year":"2010","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.intimp.2023.111168_b0045","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.intimp.2023.111168_b0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.111168_b0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMoa2112651","article-title":"event-free survival with pembrolizumab in early triple-negative breast cancer","volume":"386","author":"Schmid","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.111168_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/cells9081819","article-title":"Cholesterol and mevalonate: two metabolites involved in breast cancer progression and drug resistance through the ERR alpha pathway","volume":"9","author":"Brindisi","year":"2020","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.intimp.2023.111168_b0065","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.celrep.2019.05.104","article-title":"Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome","volume":"27","author":"Ehmsen","year":"2019","journal-title":"Cell Rep"},{"issue":"19","key":"10.1016\/j.intimp.2023.111168_b0070","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1158\/0008-5472.CAN-19-1184","article-title":"Pyrvinium pamoate induces death of triple-negative breast cancer stem-like cells and reduces metastases through effects on lipid anabolism","volume":"80","author":"Dattilo","year":"2020","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.111168_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1371\/journal.pone.0197422","article-title":"Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling","volume":"13","author":"Beckwitt","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.intimp.2023.111168_b0080","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41416-018-0267-7","article-title":"Statins attenuate outgrowth of breast cancer metastases","volume":"119","author":"Beckwitt","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2023.111168_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-019-12529-3","article-title":"ROR gamma is a targetable master regulator of cholesterol biosynthesis in a cancer subtype","volume":"10","author":"Cai","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.111168_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.intimp.2023.111168_b0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.intimp.2023.111168_b0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejpb.2007.08.002","article-title":"Use of cyclodextrins in topical formulations: Practical aspects","volume":"68","author":"Cal","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2023.111168_b0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.addr.2022.114617","article-title":"Cyclodextrins applied to the treatment of lysosomal storage disorders q","volume":"191","author":"Ishitsuka","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.intimp.2023.111168_b0110","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111168_b0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms21030898","article-title":"Differential effects of 2-hydroxypropyl-cyclodextrins on lipid accumulation in NPC1-Null Cells","volume":"21","author":"Hoque","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.111168_b0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2022.10.004","volume":"137","author":"Hastings","year":"2022","journal-title":"Mol Genet Metab"},{"issue":"333","key":"10.1016\/j.intimp.2023.111168_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2023.111168_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1371\/journal.pone.0141946","article-title":"2-Hydroxypropyl-beta-cyclodextrin acts as a novel anticancer agent","volume":"10","author":"Yokoo","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.intimp.2023.111168_b0135","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/bph.15209","article-title":"2-Hydroxypropyl-beta-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1(-\/-)Cyp46a1(-\/-) mice with deficiency in the oxysterol production","volume":"178","author":"El-Darzi","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2023.111168_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/metabo11080562","article-title":"2-Hydroxypropyl-beta-cyclodextrin regulates the epithelial to mesenchymal transition in breast cancer cells by modulating cholesterol homeostasis and endoplasmic reticulum stress","volume":"11","author":"Zhao","year":"2021","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.intimp.2023.111168_b0145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/1440-1681.12285","article-title":"Systemic administration of 2-hydroxypropyl-beta-cyclodextrin to symptomatic NPC1-deficient mice slows cholesterol sequestration in the major organs and improves liver function","volume":"41","author":"Lopez","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111168_b0150","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","article-title":"EMT, cell plasticity and metastasis","volume":"35","author":"Chaffer","year":"2016","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"10.1016\/j.intimp.2023.111168_b0155","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","article-title":"Integration of TGF-beta\/Smad and Jagged1\/Notch signalling in epithelial-to-mesenchymal transition","volume":"23","author":"Zavadil","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.intimp.2023.111168_b0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark. Res."},{"issue":"7355","key":"10.1016\/j.intimp.2023.111168_b0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2023.111168_b0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.imbio.2008.01.003","article-title":"Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways","volume":"213","author":"Ho","year":"2008","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111168_b0175","doi-asserted-by":"crossref","first-page":"1701362","DOI":"10.1080\/23723556.2019.1701362","article-title":"A master regulator of cholesterol biosynthesis constitutes a therapeutic liability of triple negative breast cancer","volume":"7","author":"Cai","year":"2020","journal-title":"Mol Cell Oncol"},{"issue":"10","key":"10.1016\/j.intimp.2023.111168_b0180","first-page":"11","article-title":"Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells","volume":"39","author":"O'Grady","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.intimp.2023.111168_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2020.118212","article-title":"Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity","volume":"259","author":"El-Ashmawy","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111168_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-021-01058-1","article-title":"Simvastatin induced ferroptosis for triple-negative breast cancer therapy","volume":"19","author":"Yao","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"11","key":"10.1016\/j.intimp.2023.111168_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/cancers13112605","article-title":"Cholesterol-induced metabolic reprogramming in breast cancer cells is mediated via the ERR alpha pathway","volume":"13","author":"Ghanbari","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.intimp.2023.111168_b0200","doi-asserted-by":"crossref","first-page":"21056","DOI":"10.3390\/ijms160921056","article-title":"Weekly treatment of 2-hydroxypropyl-beta-cyclodextrin improves intracellular cholesterol levels in LDL receptor knockout mice","volume":"16","author":"Walenbergh","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111168_b0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","article-title":"Effects of cyclodextrin in two patients with Niemann-Pick Type C disease","volume":"108","author":"Matsuo","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.intimp.2023.111168_b0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymgme.2013.04.003","article-title":"Lung toxicity of hydroxypropyl-beta-cyclodextrin infusion","volume":"109","author":"Chien","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.intimp.2023.111168_b0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.pone.0175478","article-title":"Characterization of hydroxypropyl-betacyclodextrins used in the treatment of Niemann-Pick Disease type C1","volume":"12","author":"Yergey","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2023.111168_b0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmet.2011.02.004","article-title":"Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus","volume":"13","author":"Bommer","year":"2011","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.intimp.2023.111168_b0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111168_b0230","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.3390\/ijms22126526","article-title":"Tumor-associated macrophages as multifaceted regulators of breast tumor growth","volume":"22","author":"Munir","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.111168_b0235","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2500\/ajr.2007.21.2958","article-title":"Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase","volume":"21","author":"Lin","year":"2007","journal-title":"Am J Rhinol"},{"issue":"6","key":"10.1016\/j.intimp.2023.111168_b0240","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.intimp.2023.111168_b0245","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1073\/pnas.1812266115","article-title":"Blocking IL-1\u03b2 reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation","volume":"116","author":"Kaplanov","year":"2019","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"issue":"9","key":"10.1016\/j.intimp.2023.111168_b0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C Disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.111168_b0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2021.716357","article-title":"Pro-inflammatory implications of 2-hydroxypropyl-\u03b2-cyclodextrin treatment","volume":"12","author":"Houben","year":"2021","journal-title":"Front. Immunol."},{"issue":"52","key":"10.1016\/j.intimp.2023.111168_b0260","doi-asserted-by":"crossref","first-page":"43340","DOI":"10.1074\/jbc.M112.403394","article-title":"Activation of liver X receptor induces macrophage interleukin-5 expression","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923014947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:13:03Z","timestamp":1761588783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923014947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":52,"alternative-id":["S1567576923014947"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111168","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxypropyl-\u03b2-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111168"}}